$LPCN
Lipocine Inc.

2023 Q2 Form 10-Q Financial Statement

#000149315223016293 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $55.00K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.440M $1.287M $1.244M
YoY Change 27.52% 3.51% -18.71%
% of Gross Profit
Research & Development $2.515M $3.106M $1.888M
YoY Change -13.21% 64.53% 19.49%
% of Gross Profit
Depreciation & Amortization $8.090K $4.820K $1.720K
YoY Change 213.57% 180.23%
% of Gross Profit
Operating Expenses $3.956M $4.394M $3.132M
YoY Change -1.79% 40.3% 0.7%
Operating Profit -$3.956M -$4.339M -$3.132M
YoY Change 12.14% 38.54%
Interest Expense $22.05K
YoY Change -136.75%
% of Operating Profit
Other Income/Expense, Net $407.0K $468.6K -$378.0K
YoY Change -30.25% -223.97% 89.0%
Pretax Income -$3.549M -$3.870M -$3.488M
YoY Change 34.84% 10.97% 3.49%
Income Tax $200.00 $200.00
% Of Pretax Income
Net Earnings -$3.549M -$3.870M -$3.488M
YoY Change 34.84% 10.97% 3.49%
Net Earnings / Revenue -7036.78%
Basic Earnings Per Share -$0.68 -$0.04 -$0.04
Diluted Earnings Per Share -$0.68 -$0.04 -$39.49K
COMMON SHARES
Basic Shares Outstanding 88.51M shares 88.51M shares 88.31M shares
Diluted Shares Outstanding 5.235M shares 88.51M shares 88.31M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.79M $28.87M $42.00M
YoY Change -31.03% -31.26% -7.39%
Cash & Equivalents $5.015M $4.769M $5.733M
Short-Term Investments $20.78M $24.10M $36.27M
Other Short-Term Assets $1.270M $1.706M $1.378M
YoY Change 110.48% 23.82% 199.55%
Inventory
Prepaid Expenses
Receivables $24.23K $39.06K $120.1K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $27.08M $30.61M $43.50M
YoY Change -28.87% -29.62% -5.32%
LONG-TERM ASSETS
Property, Plant & Equipment $122.7K $130.8K $32.29K
YoY Change 206.62% 304.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $23.75K $23.75K $23.75K
YoY Change 0.01% 0.01% 18.75%
Total Long-Term Assets $3.399M $3.407M $4.106M
YoY Change -17.38% -17.02% -11.51%
TOTAL ASSETS
Total Short-Term Assets $27.08M $30.61M $43.50M
Total Long-Term Assets $3.399M $3.407M $4.106M
Total Assets $30.48M $34.02M $47.60M
YoY Change -27.75% -28.53% -5.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $517.6K $796.5K $469.9K
YoY Change -36.41% 69.5% -16.09%
Accrued Expenses $1.310M $1.134M $1.568M
YoY Change 45.62% -27.7% 4.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.482M
YoY Change -55.49%
Total Short-Term Liabilities $1.827M $1.930M $3.520M
YoY Change 6.65% -45.17% -34.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $104.3K $131.7K $1.674M
YoY Change -82.34% -92.13% 23.98%
Total Long-Term Liabilities $104.3K $131.7K $1.674M
YoY Change -82.34% -92.13% -40.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.827M $1.930M $3.520M
Total Long-Term Liabilities $104.3K $131.7K $1.674M
Total Liabilities $1.931M $2.062M $5.194M
YoY Change -16.16% -60.3% -36.58%
SHAREHOLDERS EQUITY
Retained Earnings -$190.8M -$187.3M
YoY Change
Common Stock $8.852K $8.852K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $40.71K $40.71K
YoY Change
Treasury Stock Shares
Shareholders Equity $28.55M $31.96M $42.41M
YoY Change
Total Liabilities & Shareholders Equity $30.48M $34.02M $47.60M
YoY Change -27.75% -28.53% -5.88%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.549M -$3.870M -$3.488M
YoY Change 34.84% 10.97% 3.49%
Depreciation, Depletion And Amortization $8.090K $4.820K $1.720K
YoY Change 213.57% 180.23%
Cash From Operating Activities -$3.310M -$3.928M -$3.885M
YoY Change 8.64% 1.1% -4.3%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $4.000K -$26.80K
YoY Change -100.0% -114.93%
Acquisitions
YoY Change
Other Investing Activities $3.560M $5.559M $7.322M
YoY Change -6.27% -24.08% -121.54%
Cash From Investing Activities $3.560M $5.555M $7.295M
YoY Change -6.01% -23.86% -121.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.200K -$6.016K -627.4K
YoY Change -99.65% -99.04% -102.13%
NET CHANGE
Cash From Operating Activities -3.310M -$3.928M -3.885M
Cash From Investing Activities 3.560M $5.555M 7.295M
Cash From Financing Activities -5.200K -$6.016K -627.4K
Net Change In Cash 245.5K $1.621M 2.783M
YoY Change -132.65% -41.76% -132.32%
FREE CASH FLOW
Cash From Operating Activities -$3.310M -$3.928M -$3.885M
Capital Expenditures $0.00 $4.000K -$26.80K
Free Cash Flow -$3.310M -$3.932M -$3.859M
YoY Change 9.01% 1.9% -4.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001535955
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
usd
CY2022Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
usd
CY2023Q1 us-gaap Accretion Expense
AccretionExpense
usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
usd
CY2022Q1 lpcn Proceeds From Repayments Of Costs Associated With Offering
ProceedsFromRepaymentsOfCostsAssociatedWithOffering
usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 lpcn Accrued Final Payment Charge On Debt
AccruedFinalPaymentChargeOnDebt
usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q1 lpcn Dilutive Change In Common Stock Warrants
DilutiveChangeInCommonStockWarrants
usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2023Q1 lpcn Adjustment Of Warrants For Settlement Of Liability On Warrant Exercise
AdjustmentOfWarrantsForSettlementOfLiabilityOnWarrantExercise
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
796476 usd
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36357
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LIPOCINE INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0370688
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
675 Arapeen Drive
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 202
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84108
CY2023Q1 dei City Area Code
CityAreaCode
801
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
994-7383
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
LPCN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
88510791 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4769180 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3148496 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
24100430 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
29381410 usd
CY2023Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
39060 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
80427 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
579428 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
579428 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1126731 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
945319 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
30614829 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
34135080 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
3252500 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
3252500 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1158349 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1153530 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
130770 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
131589 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23753 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23753 usd
CY2023Q1 us-gaap Assets
Assets
34021852 usd
CY2022Q4 us-gaap Assets
Assets
37542922 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
600388 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1133626 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1287313 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1077738 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1930102 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1678126 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
131722 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
229856 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2061824 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1907982 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
88511 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
88511 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
9 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88516501 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88516501 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88510791 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88510791 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
8852 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8852 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219284000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219112164 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5710 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5710 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
40712 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
40712 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3241 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20321 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-187295362 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183425043 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
31960028 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
35634940 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34021852 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37542922 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54990 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3106310 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1887953 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1243687 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4393623 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3131640 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4338633 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3131640 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
370469 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
41576 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
19529 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
98134 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-377988 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
468603 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-355941 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3870030 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3487581 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3870230 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3487781 usd
CY2023Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
89 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3870319 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3487781 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88510791 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88309628 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88510791 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88309628 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3870319 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3487781 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
23562 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-49400 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3846757 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3537181 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
45570018 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3487781 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-49400 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
171028 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
205988 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
42409853 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
42409853 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
35634940 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
35634940 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3870230 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
23562 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
23562 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
177772 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
6016 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
31960028 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
31960028 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3870230 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3487781 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4819 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1719 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
177772 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
171028 usd
CY2022Q1 us-gaap Accretion Expense
AccretionExpense
4674 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-98134 usd
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
377989 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
254215 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-51282 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-41367 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-127159 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
181412 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-136540 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
196088 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-819455 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
55888 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-448557 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3928057 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3885402 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26797 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
6441243 usd
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
17906250 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
12000000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
25228474 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5554757 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7295427 usd
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
833334 usd
CY2023Q1 lpcn Proceeds From Repayments Of Costs Associated With Offering
ProceedsFromRepaymentsOfCostsAssociatedWithOffering
-6016 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
205988 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6016 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-627346 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1620684 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2782679 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3148496 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2950552 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4769180 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5733231 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
14855 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
456 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
23562 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-49400 usd
CY2022Q1 lpcn Accrued Final Payment Charge On Debt
AccruedFinalPaymentChargeOnDebt
4674 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
89 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3870230 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3487781 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88510791 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88309628 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3870230 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3487781 usd
CY2023Q1 lpcn Dilutive Change In Common Stock Warrants
DilutiveChangeInCommonStockWarrants
98134 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3968364 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3487781 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88510791 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88309628 shares
CY2023Q1 lpcn Weighted Average Effect Of Diluted Shares Outstanding
WeightedAverageEffectOfDilutedSharesOutstanding
88510791 shares
CY2022Q1 lpcn Weighted Average Effect Of Diluted Shares Outstanding
WeightedAverageEffectOfDilutedSharesOutstanding
88309628 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
24097189 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14216 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10975 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
24100430 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
29401731 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4651 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24972 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
29381410 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
24097189 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
24100430 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
24097189 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
24100430 usd
CY2023Q1 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0 usd
CY2023Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
CY2022Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
12000000.0 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25200000 usd
CY2023Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment
0 usd
CY2022Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment
0 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
28454359 usd
CY2023Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
28586081 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
32075844 usd
CY2022Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
32305700 usd
CY2023Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2100000 usd
CY2022Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1000000.0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
268017 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
59559 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
327576 usd
CY2023Q1 us-gaap Payments For Rent
PaymentsForRent
87000 usd
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
84000 usd
CY2015Q4 lpcn Class Of Warrants Or Right Redemption Price Of Warrants Or Rights
ClassOfWarrantsOrRightRedemptionPriceOfWarrantsOrRights
63.96
CY2023Q1 lpcn Class Of Warrants Or Right Redemption Price Of Warrants Or Rights
ClassOfWarrantsOrRightRedemptionPriceOfWarrantsOrRights
0.001
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
178000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
171000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
177772 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
171028 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0391 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0141 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9761 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0243 pure
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
940000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4466431 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M10D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.10
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2599610 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M17D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.08
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
229856 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-98134 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
131722 usd
CY2019Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1250000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
lpcn-20230331_pre.xml Edgar Link unprocessable
0001493152-23-016293-index-headers.html Edgar Link pending
0001493152-23-016293-index.html Edgar Link pending
0001493152-23-016293.txt Edgar Link pending
0001493152-23-016293-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
form10-q_002.jpg Edgar Link pending
lpcn-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
lpcn-20230331_cal.xml Edgar Link unprocessable
lpcn-20230331_def.xml Edgar Link unprocessable
lpcn-20230331_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending